A framework for the clinical implementation of optical genome mapping in hematologic malignancies

Area of Science:

• Genomics
• Cytogenetics
• Molecular Diagnostics

Background:

• Optical Genome Mapping (OGM) is an emerging cytogenomic technology.
• OGM demonstrates diagnostic capabilities comparable to, and sometimes exceeding, conventional methods.
• It consolidates multiple tests into a single, cost-effective assay, prompting clinical adoption.

Purpose of the Study:

• To establish a consensus framework for the clinical implementation of OGM in hematologic malignancies.
• To provide guidance on validation, quality control, and variant analysis for OGM.
• To promote globally accepted standards for OGM in clinical settings.

Main Methods:

• Formation of the International Consortium for OGM in Hematologic Malignancies.
• Consolidation of collective experience from early adopters of OGM.
• Development of practical guidance for laboratory implementation.

Main Results:

• OGM matches the diagnostic scope of standard cytogenomic testing.
• OGM provides significant additional information in specific cases.
• A framework for OGM implementation in hematologic malignancies is proposed.

Conclusions:

• OGM is a powerful tool for diagnosing hematologic malignancies.
• Standardized implementation is crucial for widespread clinical use.
• The Consortium's framework aims to ensure uniform and reliable OGM application.